Table 1. Discounted measles vaccination costs, cases, treatment costs, net costs, DALYS averted and cost per DALY averted in 2018 US$ over 2018–2047, 93 LMICs.

Discounted measles vaccination costs, treatment costs, net costs and DALYs averted
Scenario	Discounted*vaccination costs(millions)	Cases (millions)	Measles treatment costs(millions)	DALYs(millions)	Total costs(millions)
Base Case	US$10 459	490.4	US$10 014	783	US$20 473
Continuing Trends	US$11 918	213.8	US$6158	332	US$18 076
Constant Improvement	US$13 857	158.0	US$4724	230	US$18 580
Intensified Investment	US$14 794	111.5	US$3537	158	US$18 332

Cost per DALY averted
Scenario	Comparator	Net costs (millions)	DALYs averted(millions)	Cost per DALY averted	Percentage of countries meeting Ochalek threshold
Continuing Trends	Base Case	−US$2397	451	Dominant	89
Constant Improvement	Continuing Trends	US$505	102	US$4.94	76
Intensified Investment	Continuing Trends	US$256	174	US$1.47	70
Intensified Investment	Constant Improvement	−US$249	72	Dominant	80

^*The costs were discounted with a discount rate of 3%. Note: The cost-effectiveness threshold for the 92 LMICs, were estimated based on cost per DALYs averted that reflect health opportunity costs on mortality of changes in health expenditures.13

DALYs, disability-adjusted life years ; LMICs, low-income and middle-income countries.